Molecular pathways of programmed cell death in experimental Parkinson's disease

Parkinsonism Relat Disord. 2008;14 Suppl 2(Suppl 2):S176-9. doi: 10.1016/j.parkreldis.2008.04.026. Epub 2008 Jul 2.

Abstract

Dysfunction of mitochondrial complex I leads to degeneration of dopaminergic neurons of the substantia nigra pars compacta, as seen in Parkinson's disease, through activation of mitochondria-dependent programmed cell death pathways. In this scenario, complex I blockade increases the soluble pool of cytochrome c in the mitochondrial intermembrane space through oxidative mechanisms, whereas activation of pro-cell death protein Bax triggers neuronal death by permeabilizing the outer mitochondrial membrane and releasing cytochrome c into the cytosol. Targeting either Bax transcriptional or post-translational activation results in a marked attenuation of dopaminergic cell death caused by complex I inhibition.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • Electron Transport Complex I / genetics
  • Electron Transport Complex I / metabolism*
  • Humans
  • Mitochondria / metabolism
  • Parkinsonian Disorders / metabolism
  • Parkinsonian Disorders / pathology*
  • Parkinsonian Disorders / physiopathology

Substances

  • Electron Transport Complex I